Partner Content Partner Content Top 5 challenges of immuno-oncology clinical trials Learn innovative solutions to address these challenges
Partner Content Partner Content Topics Presented this February 2018 at RNA Therapeutics RNA Therapeutics 2018
Partner Content Partner Content How RACE legislation is changing the face of pediatric oncol... On August 12 of this year the US senate unanimously passed the Race to Accelerate Cures and Equity for Children Act (RACE) expanding on the already enacted Pediatric Research Equity Act (P
Partner Content Partner Content SMi Group: Exclusive Speaker Interview with Professor Nagy H... RNA Therapeutics
Partner Content Partner Content Immuno-Oncology 360° Summit The Conference Forum has announced the program line-up for the 4th annual
Partner Content Partner Content ProQR Therapeutics: RNA Therapeutics for Patients with Cysti... RNA Therapeutics
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
